Indian Exporters Fume As EU Seizes Goods-In-Transit Claiming Patent Violations
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - Large consignments of drug exports from India routed through the European Union are being confiscated on allegations of violation of local European patent laws. As per the EU patent laws, such exports are also termed as counterfeit drugs, experts say
You may also be interested in...
Indian Regulators Warn Companies Against “Unethical Promotion” Of Drugs To Doctors
MUMBAI - India's drug price regulatory body, the National Pharmaceutical Pricing Authority, has come down heavily on perpetrators of "unethical promotion of drugs" to medical practitioners, adding that such moves push up drug prices, making them unaffordable to the masses
Indian Regulators Warn Companies Against “Unethical Promotion” Of Drugs To Doctors
MUMBAI - India's drug price regulatory body, the National Pharmaceutical Pricing Authority, has come down heavily on perpetrators of "unethical promotion of drugs" to medical practitioners, adding that such moves push up drug prices, making them unaffordable to the masses
India’s Pharmexcil Revises Downward Drug Export Forecast
India's drug-exporting promoter forecasts a 10 percent decline in the growth of pharmaceutical exports in the 2008-2009 period due to the global economic slowdown. The Pharmaceutical Export Promotion Council revised its previous forecast for exports for the period, at $8.97 billion, to just $8.25 billion. That translates to a 13.9 percent growth rate rather than 23.9 predicted earlier. Pharmexcil cited the tightened credit market as a major contributor to the revised prospects, with some developing countries having to cancel expansions of their health care programs. (Click here for more